Counterfeit Drugs Produced In China Still Threaten Chinese, U.S., Global Consumers

BEIJING - Unless China does more to crack down on counterfeiting and contamination in its pharmaceutical industry, the United States could see a repeat of Chinese-made drugs or raw components causing severe adverse reactions in American hospitals, according to a Washington, D.C.-based scholar

More from Archive

More from Scrip